首页> 外文期刊>Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique >Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study
【24h】

Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study

机译:乳腺癌手术后的放疗和伴随化疗:Arcosein研究

获取原文
获取原文并翻译 | 示例
           

摘要

In breast cancer postoperative radiation therapy improves local control rate and survival. When chemotherapy and radiation are indicated, the sequencing of the two treatments is still controversial. Several studies have suggested that adjuvant radiotherapy could be safely delayed until adjuvant chemotherapy was completed. Other studies, most of them retrospective, pointed out that a delay in the initiation of radiotherapy in order to give chemotherapy first may result in an increased rate of local recurrence. Concomitant administration of the two treatments is an attractive alternative. Pilot studies have demonstrated its feasibility. A randomised phase III trial is presently in progress, comparing sequential treatment with chemotherapy first followed by irradiation and radiation versus concomitant treatment. Four-hundred and five patients have been included in 24 months. Toxicity and compliance to the treatment are reported in this evaluation.
机译:在乳腺癌中,术后放射疗法可提高局部控制率和生存率。当需要化疗和放疗时,两种治疗方法的顺序仍然存在争议。多项研究表明,辅助放疗可以安全地延迟到辅助化疗完成之前。其他研究(大多数是回顾性研究)指出,为了首先进行化学疗法而放疗的开始延迟可能导致局部复发率增加。两种治疗方法的同时给药是一种有吸引力的选择。初步研究证明了其可行性。目前正在进行一项随机的III期试验,比较先进行化疗后先进行放射治疗再进行放疗和放疗与同时治疗的顺序治疗。在24个月内收录了405位患者。该评价报告了对治疗的毒性和依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号